CeGaT at the NewCome

Ernst Pfister opened the NewCome 2011 at the Messe Stuttgart with the words: “Interested founder with innovative and sustainable business ideas can help in starting a makeover to our economy!”. To describe the short but very successful career of CeGaT Saskia Biskup she is invited along with two other founders to a panel discussion (chaired […]

CeGaT upgrades to SOLiD 5500xl

Beginning of 2011 CeGaT has ordered the SOLiD 5500xl system. As official service provider of Applied Biosystems / life technologies we will be among the first using this technology. Per run we will be able to generate up to 180 Gb (= 180.000.000.000 bases). With the new nanobeads which will be available soon this output […]

CeGaT, JSW, and NMI work on novel Alzheimer’s Disease Models

CeGaT, JSW Lifesciences GmbH, Grambach, Austria, and NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany, today announced that they will develop novel models for Alzheimer’s and related diseases based on the mitochondrial cascade hypothesis. Within the three year project, knocking-down of mitochondrial proteins will be used to elucidate the specific involvement of […]

New Retina subpanels

CeGaT introduces three additional Subpanels for Hereditary Eye Diseases: Stargardt disease and macular dystrophies (11 Genes) Cone rod dystrophies (25 Genes) Flecked retina disorders (6 Genes) We are now offering 32 Subpanels: Dementia and ALS (1 Subpanel – 20 Genes) Parkinson Syndrome (1 Subpanel – 16 Genes) Epilepsy (15 Subpanels – 265 Genes) Hereditary Eye […]

Exome Sequencing and Nature Genetics

The group of Dr. Holger Prokisch, Institute of Human Genetics, Helmholtz Zentrum, Munich, Germany, was able to identify a new gene (ACAD9) as cause of complex I deficiency, a severe mitochondrial disorder. The gene was identified through Exome Sequencing performed at CeGaT GmbH. Most interestingly, this study demonstrates how Exome Sequencing can contribute to finding […]